Sonora Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Sonora Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-400	Closed	-$4K	–	1784
2020 Q3	$4K	Buy	+400	New	+$4.23K	﹤0.01%	1529
2019 Q2	–	Sell	-794	Closed	-$12K	–	1744
2019 Q1	$12K	Hold	794	–	–	﹤0.01%	951
2018 Q4	$12K	Buy	794 +54	+7%	+$1.11K	﹤0.01%	782
2018 Q3	$16K	Buy	740 +565	+323%	+$13.1K	﹤0.01%	713
2018 Q2	$4K	Hold	175	–	–	﹤0.01%	998
2018 Q1	$2.99K	Buy	+175	New	+$3.42K	﹤0.01%	1018
2017 Q4	–	Sell	-150	Closed	-$2.64K	–	1225
2017 Q3	$2.64K	Sell	150 -149	-50%	-$3.35K	﹤0.01%	952
2017 Q2	$9.93K	Buy	+299	New	+$9.26K	﹤0.01%	729

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Sonora Investment Management's TEVA Position: Q4 2020 in Review

Sonora Investment Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2020, closing a stake of 400 shares — an estimated $4K sold.

Sonora Investment Management first reported a position in TEVA in Q2 2017 and held it in 8 quarters. The position peaked at $16K in Q3 2018. 449 funds tracked by Wall St. Rank hold TEVA as of Q4 2020.

Sonora Investment Management reported no remaining Teva Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Sonora Investment Management sold 400 Teva Pharmaceuticals shares in Q4 2020, an estimated $4K.
Sonora Investment Management first reported a position in Teva Pharmaceuticals in Q2 2017 and held it in 8 quarters.
Sonora Investment Management's Teva Pharmaceuticals position peaked at $16K in Q3 2018.
449 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2020.

Based on Sonora Investment Management's 13F filing for Q4 2020, filed 13 Jan 2021.